Hub of biotherapeutic intelligence
Frédéric Chabot
Head of Corporate Development
Frédéric Chabot is the Head of Corporate Development at ImmunoPrecise Antibodies (IPA), focusing on M&A, strategic partnerships, and corporate initiatives. He began working with IPA in 2017, contributing in various roles before assuming his current position. With over 26 years of experience in finance and corporate strategy, he navigates biotech investments and market expansion.
Previously, he served as an International Liaison at Contact Financial, an advisory firm specializing in capital raising and investor relations for TSX and TSX-V listed companies. Over nine years, he worked on investor awareness programs and fundraising initiatives, supporting startups and early-stage companies.